Potential new treatment for Fragile X targets one gene to affect many

(Rockefeller University) Scientists found that inhibiting a regulatory protein alters the intricate signaling chemistry that is responsible for many of the disease's symptoms. The findings provide a path to possible therapeutics for disorders associated with Fragile X.